OXYLONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxylone, and what generic alternatives are available?
Oxylone is a drug marketed by Pharmacia And Upjohn and is included in one NDA.
The generic ingredient in OXYLONE is fluorometholone. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the fluorometholone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxylone
A generic version of OXYLONE was approved as fluorometholone by AMNEAL on January 9th, 2024.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXYLONE?
- What are the global sales for OXYLONE?
- What is Average Wholesale Price for OXYLONE?
Summary for OXYLONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 6,324 |
| DailyMed Link: | OXYLONE at DailyMed |
US Patents and Regulatory Information for OXYLONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | OXYLONE | fluorometholone | CREAM;TOPICAL | 011748-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
